MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, ALNY has $4,966,331K in assets. $4,177,155K in debts. $1,657,250K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
276.24%
Quick Ratio
270.60%
Cash Ratio
113.02%
Debt to Asset Ratio
84.11%
Assets Breakdown
    • Cash and cash equivalents
    • Marketable debt securities
    • Accounts receivable, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Liabilities related to the sale ...
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-12-31
Cash and cash equivalents
1,657,250
Marketable debt securities
1,251,234
Marketable equity securities
0
Accounts receivable, net
777,567
Inventory
82,719
Prepaid expenses and other current assets
281,892
Total current assets
4,050,662
Property, plant and equipment, net
513,147
Operating lease right-of-use assets
194,916
Deferred tax assets
125,975
Restricted investments
22,170
Other assets
59,461
Total assets
4,966,331
Accounts payable
115,721
Accrued expenses
1,080,197
Operating lease liabilities
45,518
Deferred revenue
4,845
Liabilities related to the sale of future royalties and development funding
220,068
Development derivative liability
0
Total current liabilities
1,466,349
Operating lease liabilities, net of current portion
225,087
Convertible debt
1,007,784
Liabilities related to the sale of future royalties and development funding, net of current portion
1,470,341
Development derivative liability, net of current portion
0
Other liabilities
7,594
Total liabilities
4,177,155
Common stock, 0.01 par value per share, 250,000 shares authorized as of december31, 2025 and december31, 2024, respectively 132,376 shares issued and outstanding as of december31, 2025 129,294 shares issued and outstanding as of december31, 2024
1,324
Additional paid-in capital
7,510,473
Accumulated other comprehensive loss
-20,097
Accumulated deficit
-6,702,524
Total stockholders' equity
789,176
Total liabilities and stockholders' equity
4,966,331
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Prepaid expenses andother current assets$281,892K Inventory$82,719K Accounts receivable, net$777,567K Marketable debt securities$1,251,234K Cash and cashequivalents$1,657,250K Other assets$59,461K Restricted investments$22,170K Deferred tax assets$125,975K Operating leaseright-of-use assets$194,916K Property, plant andequipment, net$513,147K Total current assets$4,050,662K Total assets$4,966,331K Total liabilities andstockholders' equity$4,966,331K Total stockholders'equity$789,176K Total liabilities$4,177,155K Accumulated deficit-$6,702,524K Accumulated othercomprehensive loss-$20,097K Additional paid-in capital$7,510,473K Other liabilities$7,594K Liabilities related to thesale of future...$1,470,341K Convertible debt$1,007,784K Operating leaseliabilities, net of current...$225,087K Total currentliabilities$1,466,349K Common stock, 0.01 parvalue per share,...$1,324K Liabilities related to thesale of future...$220,068K Deferred revenue$4,845K Operating leaseliabilities$45,518K Accrued expenses$1,080,197K Accounts payable$115,721K

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

ALNYLAM PHARMACEUTICALS, INC. (ALNY)